Has Whitney Beam received payments from drug or device companies?

Yes. Drug and device makers reported $7,100 in general payments to Whitney Beam across 229 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Whitney Beam did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Whitney Beam come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Whitney Beam

Family · Lansing, MINPI 1932713294

Payments from drug & device makers

$7,100in general payments, 2019–2025

Across 229 payments — averaging $31.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Insulet Corporation$3K
Dexcom, Inc.$866
Medtronic$774
Tandem Diabetes Care, Inc.$566
Ascendis Pharma Endocrinology Inc$323
Abbott$321
plus $1K from 25 others

What the payments were for

Food & beverage$7,098100%
Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Insulet Corporation	70	$2,769
Dexcom, Inc.	32	$866
Medtronic	16	$774
Tandem Diabetes Care, Inc.	17	$566
Ascendis Pharma Endocrinology Inc	13	$323
Abbott	12	$321
Azurity Pharmaceuticals, Inc.	12	$231
Xeris Pharmaceuticals, Inc.	6	$221
Sanofi-aventis U.S. LLC	8	$196
UCB, Inc.	5	$104
Amphastar Pharmaceuticals, Inc.	4	$78
Regeneron Healthcare Solutions, Inc.	3	$62
AstraZeneca	3	$58
QOL Medical, LLC	3	$51
180 Medical, Inc.	3	$50
Tolmar, Inc.	2	$45
Novo Nordisk	2	$44
Soleno Therapeutics, Inc.	1	$40
Nestle Healthcare Nutrition Inc.	2	$39
AbbVie	2	$39
Takeda Pharmaceuticals U.S.A., Inc.	2	$36
Ipsen Biopharmaceuticals, Inc	2	$35
Eton Pharmaceuticals, Inc.	1	$24
BETA Bionics, Inc.	1	$21
Sequel Med Tech, LLC	1	$21
Endo Pharmaceuticals Inc.	1	$21
Biomarin Pharmaceutical Inc.	1	$20
Amneal Pharmaceuticals LLC	1	$16
Phadia US Inc.	1	$15
Mirum Pharmaceuticals, Inc.	1	$14
Travere Therapeutics, Inc.	1	$2

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,100 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metformin Hcl	11	$21
Simvastatin	11	$16

Paid to pharmacies, not to this prescriber.

Other family in Lansing

Iris ZinkLansing$37K
Jayme HeimGrandville$663K
Susan WolgamottBloomfield Township$327K
Elisheva EllenbergDetroit$150K
Sarah JohnsonFarmington Hills$119K
Daniela MaximTroy$112K
Kelsey PrinceGrand Rapids$87K
Brent MillerFremont$66K
Rachael CompeauFlint$62K
David KocendaLapeer$49K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →